Loading term…
Use of real-world data (e.g., claims, EHR, registries) to evaluate or validate safety signals, estimate rates, or assess confounders.
Using Sentinel or similar to assess background rates and disproportionality.
EMA RWE paper, FDA Sentinel
Using RWD without protocol or predefined analysis plan.
Describe a signal evaluation where you used RWD and the methodology.